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The integral membrane protein M2 of influenza virus forms pHgated proton channels in the viral lipid envelope 1 . The low pH of an endosome activates the M2 channel before haemagglutininmediated fusion. Conductance of protons acidifies the viral interior and thereby facilitates dissociation of the matrix protein from the viral nucleoproteins-a required process for unpacking of the viral genome 2 . In addition to its role in release of viral nucleoproteins, M2 in the trans-Golgi network (TGN) membrane prevents premature conformational rearrangement of newly synthesized haemagglutinin during transport to the cell surface by equilibrating the pH of the TGN with that of the host cell cytoplasm 3 . Inhibiting the proton conductance of M2 using the anti-viral drug amantadine or rimantadine inhibits viral replication [4] [5] [6] [7] . Here we present the structure of the tetrameric M2 channel in complex with rimantadine, determined by NMR. In the closed state, four tightly packed transmembrane helices define a narrow channel, in which a 'tryptophan gate' is locked by intermolecular interactions with aspartic acid. A carboxy-terminal, amphipathic helix oriented nearly perpendicular to the transmembrane helix forms an inward-facing base. Lowering the pH destabilizes the transmembrane helical packing and unlocks the gate, admitting water to conduct protons, whereas the C-terminal base remains intact, preventing dissociation of the tetramer. Rimantadine binds at four equivalent sites near the gate on the lipid-facing side of the channel and stabilizes the closed conformation of the pore. Drugresistance mutations are predicted to counter the effect of drug binding by either increasing the hydrophilicity of the pore or weakening helix-helix packing, thus facilitating channel opening.
M2 is a 97-residue single-pass membrane protein that has its amino and carboxy termini directed towards the outside and inside of the virion, respectively; it is a homotetramer in its native state 8, 9 . The four transmembrane helices form a channel in which His 37 is the pH sensor and Trp 41 is the gate 6, 10, 11 . The adamantane-based drugs amantadine and rimantadine, which target the M2 channel, have been used as first-choice antiviral drugs against community outbreaks of influenza A viruses for many years, but resistance to the adamantanes has recently become widespread. Many structural models of this channel have been built, based on sequence analysis, mutagenesis and solid-state NMR 8, 11, 12 . Many of these studies have been done on inherently unstable transmembrane-only constructs, however, leading to conflicting structural conclusions.
Although the transmembrane-only peptide fails to form a stable tetramer, a construct of residues 18-60 (M2(18-60)), which includes 15 residues of the C terminus in addition to the transmembrane region, forms a stable tetramer in dihexanoyl-phosphatidyl-choline (DHPC) detergent micelles and yields high-resolution NMR spectra ( Supplementary Fig. 1 ). In the closed conformation at pH 7.5, M2(18-60) is a homotetramer in which each subunit has an unstructured N terminus (residues 18-23), a channel-forming transmembrane helix (residues 25-46), a short flexible loop (residues 47-50) and a C-terminal amphipathic helix (residues 51-59). The transmembrane helices assemble into a four-helix bundle with a lefthanded twist angle of ,23u and a well defined pore (Fig. 1) . A ring of methyl groups from Val 27 constricts the N-terminal end of the pore to ,3.1 Å (inner diameter). In agreement with proposed models 11, 13 , His 37 and Trp 41 are inside the pore. A three-bond, 15 N- 13 Cc scalar coupling ( 3 J NCc ) value of 1.5 Hz (Supplementary Table 1) shows the His 37 x 1 rotamer to be predominantly trans, but with significant rotameric averaging. The x 1 of Trp 41 is essentially locked in the trans position, as determined by a 3 J NCc of 2.6 Hz, whereas the x 2 is also fixed at around 2120u by the side chain He1-Ne1 dipolar coupling and nuclear Overhauser effects (NOEs). The Trp 41 indole rings are at van der Waals distance from each other, prohibiting passage of water or ions (Fig. 1c) . The indole He1 of one subunit is on average 3.5 Å from the Asp 44 carboxyl carbon of the adjacent subunit. The two residues can form an intermolecular hydrogen bond that stabilizes the closed Trp 41 gate. The side chain of Arg 45 probably participates in an intermolecular interaction with Asp 44. These findings are consistent with the increased pH-modulated activity of channels in which asparagine has replaced Asp 44 (ref. 14) .
The C-terminal end of the channel extends into a loop (residues 47-50) that connects the transmembrane domain to the C-terminal amphipathic helix. Residual dipolar couplings (RDCs) and intra-and inter-monomer NOEs show that the amphipathic helices lie roughly perpendicular (,82u) to the transmembrane helices and assemble head-to-tail using a right-handed packing mode to form the base of the channel. The orientation and amphipathic character of the amphipathic helices suggest that the C-terminal base lies on the surface of the membrane.
Residues 47-50 give no NOE peaks and do not have a stable, hydrogen-bonded structure in the detergent micelles used in our work. We believe that this segment adopts a more stable conformation in the viral membrane because Cys 50, which we mutated to serine to avoid disulphide formation, is normally palmitoylated 15 . Modelling shows that extending the transmembrane helix to Phe 48 would place residue 50 facing the membrane, allowing for insertion of the palmitoyl acyl chain into the lipid bilayer. This minor rearrangement would also move the amphipathic helices closer to the transmembrane domain.
Drug binding stabilizes the closed conformation. On addition of drug, the resonances of residues 43-46 at the C terminus of the channel, which are severely exchange-broadened in the drug-free sample, became significantly sharper and more homogeneous ( Supplementary Fig. 2 ). The protein-drug NOEs collected from four different NOE spectroscopy (NOESY) spectra ( Supplementary  Fig. 3 ) place the binding site between adjacent helices at the C-terminal end of the transmembrane domain near the Trp 41 gate, on the membrane side of the channel (Fig. 1d) . We could not detect drug NOEs in other parts of the protein, including the widely proposed drug-binding site in the pore of the channel. The amine headgroup of rimantadine is in contact with the polar side chains of Asp 44 and Arg 45, and with the indole amine of Trp 41. The side chains of Ile 42 from one helix and Leu 40 and Leu 43 from another helix form the hydrophobic walls of the binding pocket that interact with the adamantane group of rimantadine. Thus, rimantadine covers a unique polar patch in the otherwise hydrophobic environment of the transmembrane domain. Interactions between rimantadine and the channel are consistent with structure-activity relationships of the adamantane group 16 . In particular, the basic nitrogen group and size limits at the methyl site are critical. These requirements are the result of the interactions with Asp 44 and the small hydrophobic pocket around Ile 42, respectively.
Water NOEs measured in the 110-ms 15 N-separated NOESY experiments give a clear picture of water distribution relative to the channel (Fig. 2) . The lipid-facing surface of the transmembrane region is largely protected from water by the DHPC micelle. In the closed channel pore, the Val 27 ring at the N terminus and the Trp 41 gate at the C terminus essentially block water from freely diffusing into the pore from either side of the membrane. Within the transmembrane region, only the amides of Ser 31 and Ile 32 have NOE crosspeaks at the chemical shift of water, probably corresponding to the hydroxyl proton of Ser 31 in exchange with water. A polar residue is present at position 31 in all sequenced variants of M2, suggesting that proton conduction requires water to be bound to this site. This water may serve to bridge the proton relay from the N-terminal end of the pore to the His 37 pH sensor. Water was detected at the C terminus of the transmembrane region, beginning at Arg 45. The He1 of the Trp 41 indole ring, which points towards the C-terminal side of the pore, also has a strong NOE to water, indicating that the base of the channel is accessible to bulk water.
Lowering the pH from 7.5 to 6.5 broadens most of the NMR resonances corresponding to the transmembrane helix (Fig. 3a) . The resonance broadening could not be attributed to protein aggregation, because the self-diffusion coefficients were essentially unchanged between pH 7.5 and pH 6.5. Thus, activation of the channel is coupled to increased conformational exchange in the transmembrane domain. In contrast, the resonances of the amphipathic helices are essentially unaffected by lowering the pH, indicating that the C-terminal base of the tetramer remains intact as the channel opens.
In addition to destabilizing helix-helix packing in the transmembrane domain, channel activation must also correlate with increased dynamics of the Trp 41 gate. Because the indole amide resonance of Trp 41 remained strong as the pH was lowered from 7.5 to 6.0, it serves as a useful NMR probe for monitoring opening of the channel. We compared the millisecond timescale dynamics of the Trp 41 indole ring between the closed and open states by carrying out relaxation-compensated Carr-Purcell-Meiboom-Gill (CPMG) experiments 17 at pH 7.5, pH 7.0 and pH 6.0. A two-site exchange model fits the dependence of 15 N relaxation caused by chemical shift exchange on the frequency of refocusing (1/t cp ) of chemical shift evolution (Fig. 3b) , implying that the gate switches between two configurations at any given pH. As the pH was lowered from 7.5 to 6.0, the rate of fluctuation increased by more than fourfold (Fig. 3b) , indicating that channel activation 'unlocks' the gate. Adding rimantadine to the channel at an intermediate pH of 7.0 slowed the timescale of the gate motion to nearly that of a drug-free gate at pH 7.5 (Fig. 3c) . These results confirm that the reconstituted channels in thẽ 9 . Thus, the transmembrane helices are tethered at one end by N-terminal disulphides and at the other end by the C-terminal base, ensuring that destabilization of the fourhelix bundle during channel activation does not cause dissociation of the tetramer (Fig. 4) . Indeed, truncation of the amphipathic helix results in channels that rapidly lose channel activity 18 . The discovery of the external drug-binding site was unexpected. Drug-resistance mutations seemed to suggest that the drug-binding site was inside the pore, because, in early models of the channel, residues that lead to drug resistance were predicted to be pore-lining. The known mutations that confer drug resistance are L26F, V27A, A30T, S31N, G34E and L38F. Mapping these residues onto the structure ( Supplementary Fig. 7 ) reveals that Val 27, Ala 30 and Gly 34 are pore-lining, but that Leu 26, Ser 31 and Leu 38 are in the helix-helix packing interface. Moreover, these mutations are spread out over more than three turns of the transmembrane helix, covering a distance much larger than the dimensions of amantadine or rimantadine. The authors of ref. 19 pointed out that having a corkplugging-the-bottle model is insufficient to explain all the results of electrophysiology studies. For example, drug inhibition is more effective when applied to the closed channel than to the open channel, which is not expected of a pore-blocking mechanism 5 . Several of the drug-resistance mutations in pore-lining residues have been shown to retain drug binding 20 . Although a pore blocker is expected to fit tightly in the pore, channel inhibition is unusually tolerant of modifications to the adamantane scaffold 16 . Together, the above observations suggest an allosteric inhibition mechanism.
Is the external binding site consistent with all drug-resistance mutations? Although the exact structural effects of resistance mutations are difficult to predict, what they do have in common is that they either perturb the helix-helix interface (L26F, V27A, S31N,  L38F ) or increase the hydrophilicity of the pore (A30T, G34E). 
LETTERS
From this observation, and from detection of a conformational exchange among multiple states at lowered pH, we propose an allosteric inhibition mechanism that can account for all of the mutations. In our model, drug binding makes the closed channel harder to open, whereas drug-resistance mutations destabilize the closed channel, making it easier to open. Replacing Val 27 with alanine enlarges the N-terminal opening and weakens helix-helix packing, and therefore may facilitate channel opening. Ala 30 and Gly 34 are inside the pore, and replacing them with threonine and glutamate, respectively, may facilitate pore hydration, and, in turn, channel opening. Leu 26, Ser 31 and Leu 38 are helix-helix interface residues; their mutations probably perturb helix-helix packing and lower the energetic cost of channel opening. Why, then, are no drug-resistant mutations observed near the drug-binding site? In fact, few mutations are ever observed in this region of the channel (drug-resistant or otherwise), which is not surprising owing to the functional constraints placed on these residues in proximity to the channel pH sensor (His 37) and the channel gate (Trp 41). As the structure illustrates, intermolecular contacts between Asp 44 and Arg 45 form an integral part of the channel gate, along with Trp 41. The residues that form the hydrophobic walls of the binding pocket-Leu 40, Ile 42 and Leu 43-are on the lipid face of the channel and must retain hydrophobicity for membrane partitioning. To accommodate the Trp 41 indole rings within the channel, the helices splay slightly at the C terminus of the transmembrane domain, and interhelical contacts below Leu 38-with the exception of the Trp 41 side chains-are no longer important for channel assembly. Thus, residues essential to channel assembly are in the N-terminal half of the transmembrane helix, exactly where drugresistance mutations occur.
Binding from the membrane side is consistent with the high membrane partition coefficient of adamantane drugs, which effectively concentrates them in the membrane and lowers their level in the aqueous phase 21, 22 . Adamantanes interact with a number of other ion channels, including viroporins from hepatitis C 23 , the potassium channel Kcv of the chlorella virus PBCV-1 (ref. 24 ) and the human NMDA receptors 25 . Hanatoxin, an allosteric inhibitor of voltagegated K 1 channels with a high membrane partition coefficient, also has an external binding site 26, 27 . Membrane-side binding may thus be a feature of many channel inhibitors. This mode of inhibition could be advantageous for drug design because drug molecules are typically much larger than hydrated ions selected by ion channels, and therefore the energy barrier for the drug to find a blocking site inside the channel pores would be much higher than targeting a functional site from the membrane side of the channel. Note added in proof: We note that, in a separate X-ray study of the transmembrane domain of M2, an electron density, which was proposed to be from amantadine, was observed inside the channel pore (see ref. 28 ).
METHODS SUMMARY
The M2(18-60) polypeptide construct was expressed as a C-terminal fusion to bacterial trpLE with an N-terminal His 9 tag in the pMM-LR6 vector 29 . The M2(18-60) tetramer was reconstituted by dissolving peptide in a solution containing 50 mM sodium phosphate, 6 M guanidine HCl and 150 mM DHPC, dialyzing against a solution containing 40 mM sodium phosphate (pH 7.5) and 30 mM glutamate, and concentrating. Rimantadine was added to the reconstituted protein. The final NMR sample used for structure determination contained 0.75 mM M2(18-60) (monomer), ,300 mM DHPC and 40 mM rimantadine. Given that the DHPC has an aggregation number of 27 (ref. 30) and the strong partition coefficient of rimantadine in phospholipids (rimantadine aqueous solubility is very low, ,50 mM), locally, there are about four rimantadine molecules per micelle compartment in which the channel resides.
The NMR protocol used was similar to that described previously 31 . An extensive set of structural restraints (including 230 3 4 intra-and 27 3 4 inter-molecular distance restraints derived from NOEs, 27 3 4 orientation restraints from residual dipolar couplings (RDCs), and 23 3 4 side-chain rotamers from three-bond scalar couplings) were used to generate an ensemble of 15 low-energy structures with a backbone root mean square (r.m.s.) deviation of 0.30 Å for the channel region and of 0.89 Å for all structured regions (Fig. 1a) . The refinement statistics and NMR-derived restraints are summarized in Supplementary Table 1 . Structure calculation was accomplished in two steps, in which the overall tetramer conformation was first defined by NOE-derived distance restraints and J-coupling-derived dihedral restraints using a hightemperature simulated annealing protocol, and was subsequently refined against RDCs at low temperature.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
